NASDAQ:LMAT   LeMaitre Vascular, Inc.
Sales grew 9% to $28.4 million. That was well ahead of the $25.9 million that analysts had projected.
Operating income surged 14% to $7.2 million.
Net income grew 41% to $6 million, or $0.30 per share. That figure blew past the $0.20 that Wall Street was expecting.
The board of directors approved a 21% increase to the quarterly dividend and gave the thumbs-up to repurchasing $10 million shares of common stock.
Zooming out to the full year, here's how the company performed in 2018:

Revenue jumped 5% to $105.6 million. That was solidly ahead of the $103 million that was expected.
Net income grew 34% to $22.9 million. However, the bulk of the increase is attributable to one-time gains on business divestitures and acquisitions.
EPS jumped 31% to $1.13. This was comfortably above the $1.04 that market watchers were expecting.

finance.yahoo.c...-161800004.html?.tsrc=rss


Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.